Ppd Pharmaceutical Development India Private Limited - Due diligence report

A 360° intelligence report on Ppd: trust score, financial health, credit view, compliance, directors, growth and distress signals - generate…

2004-02-10 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
View plans Plan
PP Ppd Pharmaceutical Development India Private Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Ppd — 360° Intelligence Report

Generated from MCA filings & public records
95/100
Trust Score
Low Risk

Ppd is assessed as Low Risk with a Trust Score of 95/100. Ppd is an active private limited indian non-government company incorporated in 2004, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 08 Jul 2026 from the latest processed filings. Ppd Pharmaceutical Development India Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
95/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 6 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
RASHMI RAJA CHITGUPI 01234567 Director 01/04/2018 6 yrs Approved
HEMANT SHAH 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Ppd Uk Holdings Limited
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)
Group entityRelationship% held
Ppd Uk Holdings Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 90 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Operating for 22+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence95/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment95/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view93/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
26 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
30 Nov 2020
Director ceased
RASHMI RAJA CHITGUPI
Director ceased
HEMANT SHAH
16 Oct 2020
Director appointed
RASHMI RAJA CHITGUPI (Director)
23 Sep 2020
Director ceased
NANJARAJE SIDDARAJE URS
19 Aug 2020
Director ceased
MATTHEW GUNN
18 Aug 2020
Director appointed
HEMANT SHAH (Director)
31 Mar 2020
Director ceased
CHRISTOPHER DAVID NEILD
18 Jan 2019
Securities allotted
15250 Equity Shares - 70.46 cr raised
15 Dec 2016
Director ceased
JULIA MARY JAMES
15 Jul 2016
Director ceased
BRAINARD JUDD HARTMAN
03 Feb 2012
Director ceased
EDWARD CHIYUAN IAN
01 Jan 2011
Director ceased
RAJARSHI CHAKRABARTI
Director ceased
AJIT LAXMIKANT ANEKAR
10

Key Observations

Auto-generated from the data above
Revenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
6 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Aurigene Pharmaceutical U74999KA2019PLC127964 Bangalore, Karnataka, India
Sabic Research & Technology Private Limited U74110KA1998PTC080762 Bengaluru, Karnataka, India
Lambda Therapeutic U24236GJ1998PLC034883 Ahmedabad, Gujarat, India
Cliantha Research U73100GJ2004PLC044669 Ahmedabad, Gujarat, India
Rubicon L73100MH1999PLC119744 Thane, Maharashtra, India
Icon U74110TN2004PTC054137 Chennai, Tamil Nadu, India
Baxter International U74999KA2017PTC109068 Bangalore North, Karnataka, India
Eisai U21002AP2007PTC053247 Paravada, Andhra Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Ppd before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Ppd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Ppd - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 95/100, distress signals and MSME payment-delay disclosures - know whether Ppd pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Ppd - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Ppd an active company?

Ppd has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Ppd financially healthy?

Ppd has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Ppd?

Its overall Trust Score is 95/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Ppd?

The ultimate holding entity is Ppd Uk Holdings Limited. 2 active director(s) are on record.

Does Ppd have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Ppd up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Ppd?

Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.